T-cell engagers to drive immuno-oncology next growth wave: GlobalData EP News Bureau Aug 12, 2025 Bispecific T-cell engagers forecast to expand from 10% to 35% of the global immuno-oncology market by 2031 as immune checkpoint…
WuXi Biologics and GSK enter into licence agreement on multiple T Cell Engagers EP News Bureau Jan 6, 2023 WuXi Biologics will receive a $40 million upfront payment and up to $1.46 billion in additional payments for research,…
